Exhibit 10.1 AMENDED ASSET PURCHASE & ROYALTY AGREEMENT THIS AMENDED ASSET PURCHASE & ROYALTY AGREEMENT ("Agreement") effective as of the 28th day of December, 2007, amends the AGREEMENT dated the 13th day of February, 2007, by and between DAYCON...Royalty Agreement • January 4th, 2008 • Cavit Sciences, Inc. • Pharmaceutical preparations • Florida
SUBSCRIPTION AND PURCHASE AGREEMENT FOR BOLLENTE INTERNATIONAL, INC. Offering of up to $1,000,000 Offering Price of $25,000 Per Unit Each Unit Represents 0.625% of Gross Margin Total Units Offered Forty (40) Total Offering Represents 25% of Gross...Royalty Agreement • November 3rd, 2016 • Bollente Companies Inc. • Household appliances • Nevada
Persons interested in purchasing Units of Bollente International, Inc. (“Company”) must complete and return this Agreement along with their check or money order to:
ROYALTY AGREEMENTRoyalty Agreement • June 8th, 2015 • CMG Holdings Group, Inc. • Services-advertising • Delaware
This Royalty Agreement (the “Agreement”) is made and entered into as of _______, 2011 by and between CMG Holdings Group, Inc., a Nevada corporation (“CMGO”) and Audio Eye, Inc., a Delaware corporation (“AE”) with reference to the following:
ROYALTY AGREEMENT BETWEEN BIOVEST INTERNATIONAL, INC. AND ACCENTIA BIOPHARMACEUTICALS, INC.Royalty Agreement • December 29th, 2006 • Biovest International Inc • Pharmaceutical preparations • Delaware
This Royalty Agreement (this “Agreement”) effective as of October 31, 2006, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“Biovest”) and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (“Accentia”) (collectively the “Parties”).
ROYALTY AGREEMENT BETWEEN LEAP THERAPEUTICS, INC. AND LEAP SHAREHOLDER ROYALTY VEHICLE, LLCRoyalty Agreement • January 26th, 2017 • Leap Therapeutics, Inc. • Pharmaceutical preparations
THIS ROYALTY AGREEMENT (this “Agreement”) is entered into as of January 23, 2017 (the “Effective Date”), by and between Leap Therapeutics, Inc., a Delaware corporation (“Company” or “Leap”), and Leap Shareholder Royalty Vehicle, LLC, a Delaware limited liability company (“Leap SRV”). Company and Leap SRV are sometimes referred to herein individually as a “Party” and collectively as “Parties.”
ROYALTY AGREEMENTRoyalty Agreement • November 12th, 2013 • Biotime Inc • Biological products, (no disgnostic substances) • California
This Royalty Agreement ("Agreement") is made as of October 1, 2013 (“Effective Date”) by and between Asterias Biotherapeutics, Inc., a Delaware corporation (“Asterias”), and Geron Corp., a Delaware corporation (“Geron”).
ROYALTY AGREEMENTRoyalty Agreement • May 20th, 2015 • Westport Energy Holdings Inc. • Industrial organic chemicals • New Jersey
THIS ROYALTY AGREEMENT (this “Royalty Agreement”), made and entered into as of February 5, 2014 (the “Execution Date”), is by and between WESTPORT ENERGY LLC, a Delaware limited liability company (the “Westport”) and YA GLOBAL INVESTMENTS, L.P. (the “Holder”). Collectively, Westport and the Holder are referred to as the “Parties.”
RECITALSRoyalty Agreement • December 29th, 1999 • Carbite Golf Inc • California
ContractRoyalty Agreement • May 5th, 2020 • New York
EXECUTION VERSION ROYALTY AGREEMENT dated as of May 31, 2017 by and between AZIYO MED, LLC and LIGAND PHARMACEUTICALS INCORPORATED
ROYALTY AGREEMENT BETWEEN BIOVEST INTERNATIONAL, INC. AND VALENS OFFSHORE SPV II, CORP.Royalty Agreement • December 11th, 2007 • Biovest International Inc • Pharmaceutical preparations • Delaware
This Royalty Agreement (this “Agreement”) effective as of December 10, 2007, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“Biovest”) and VALENS OFFSHORE SPV II, CORP. (“Valens Offshore”) (collectively the “Parties”).
ROYALTY AGREEMENTRoyalty Agreement • July 24th, 2012 • Royal Standard Minerals Inc • Metal mining • Nevada
This ROYALTY AGREEMENT (as amended, modified, supplemented or restated, this “Agreement”) is made and entered into as of August 26, 2011, by and between MANHATTAN MINING CO., a corporation organized and existing under the State of Nevada, whose address is 1 Main Street, Manhattan, Nevada 89022, as the grantor (the “Company”) and WATERTON GLOBAL VALUE, L.P., by the general partner of its general partner, Cortleigh Limited, whose address is Folio House, P.O. Box 800, Road Town, Tortola, VG1110, as the grantee (the “Royalty Holder”).
InterGrain Industry Standard Seed License & Royalty AgreementRoyalty Agreement • January 30th, 2022
Royalty AgreementRoyalty Agreement • September 9th, 2016 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
This Royalty Agreement (this “Agreement”) is dated as of September 6, 2016 and is between GUIDED THERAPEUTICS, INC., a Delaware corporation (the “Company”), JOHN E. IMHOFF (“Imhoff”), and DOLORES M. MALOOF (“Maloof”).
ROYALTY AGREEMENT THIS AGREEMENT made as of the 14th day of June, 2006.Royalty Agreement • September 25th, 2006 • Liberty Petroleum Inc
STONE PETROLEUMS LTD., SUPERNOVA RESOURCES LTD., 349385 ALBERTA LTD. and TORLAND LTD., bodies corporate, of the City of Calgary, in the Province of Alberta,
CONFIDENTIAL TREATMENT REQUESTED ROYALTY AGREEMENTRoyalty Agreement • June 30th, 2015 • Natera, Inc. • Services-medical laboratories • New York
This ROYALTY AGREEMENT, dated as of April 18, 2013 (as amended, supplemented or otherwise modified from time to time, this “Royalty Agreement”), is made by and between ROYALTY OPPORTUNITIES S.ÀR.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees and assignees, “ROS”), and Natera, Inc., a Delaware corporation (“Natera”). ROS and Natera are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
ContractRoyalty Agreement • November 20th, 2020 • Nanobiotix S.A. • Pharmaceutical preparations
To: Nanobiotix (the “Borrower”) 60 rue de Wattignies 75012 Paris France Attention: Finance Department and Nanobiotix Corp. (the “Guarantor”) 210 Broadway, NGIN 2nd floor, Cambridge, Massachusetts, United States Attention: Philippe Mauberna, Treasurer
CERTAIN INFORMATION IDENTIFIED WITH THE MARK “(***)” AND “(***%***)” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. Execution Version ROYALTY AGREEMENTRoyalty Agreement • May 5th, 2020 • Pennsylvania
This Royalty Agreement dated as of July 19, 2019 (as amended, supplemented or otherwise modified from time to time, this “Royalty Agreement”) is made by Michael F. Cola, Joseph J. Grano, Jr., Kathleen Jane Grano, Joseph C. Grano, The Grano Children’s Trust, Joseph C. Grano, trustee and LeoGroup Private Investment Access, LLC on behalf of Garry A. Neil (each individually, an “Investor” and collectively, the “Investors”) and Aevi Genomic Medicine, Inc. (“Aevi”). Investors and Aevi are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
September 7 , 2004 Northern Mining Explorations Ltd. Place du CanadaRoyalty Agreement • February 10th, 2005 • Tan Range Exploration Corp • Gold and silver ores
Those agreements copied in Schedule “A’ attached hereto (“Underlying Agreements”) concerning those mineral properties located in Tanzania and more particularly described in Schedule
ROYALTY AGREEMENTRoyalty Agreement • October 27th, 2020 • PureTech Health PLC • Pharmaceutical preparations • Massachusetts
This ROYALTY AGREEMENT (the “Agreement”), dated as of July 23, 2013, is by and among (i) PureTech Ventures, LLC, a Delaware limited liability company (“PureTech”), and (ii) Follica, Incorporated, a Delaware corporation (the “Company”).
AMENDMENT TO ROYALTY AGREEMENTRoyalty Agreement • June 7th, 2012 • Royal Standard Minerals Inc • Metal mining • Nevada
THIS AMENDMENT TO ROYALTY AGREEMENT (the "Amendment") is made and entered into effective as of the 2nd day of May, 2012, by and between MANHATTAN MINING CO., a corporation organized and existing under the laws of the State of Nevada, whose address is 1 Main Street, Manhattan, Nevada 89022 (the "Company"), and WATERTON GLOBAL VALUE, L.P., by the general partner of its general partner, Cortleigh Limited, whose address is Folio House, P.O. Box 800, Road Town, Tortola, VG1110 (the “Royalty Holder”).
Re: Option Agreement – Project 1493, LLCRoyalty Agreement • July 30th, 2021 • British Columbia
Further to the indicative term sheet (the “Term Sheet”) between Chemesis International Inc. (“Chemesis”) and GSRX Industries Inc. (“GSRX”), which sets forth out the general terms for the grant by Project 1493, LLC (“1493”) to Chemesis’ subsidiary, Natural Ventures PR, LLC (“NVPR”), an option (the “Option”) under which NVPR, or its Affiliate, can acquire 100% of the issued and outstanding membership interest of 1493 (the “1493 Membership Interest”), the agreement (“Agreement”) is intended to set forth, on a definitive basis, our agreement regarding the Option (the “Transaction”). This Agreement is binding and enforceable between the Parties and will remain in full force and effect unless and until terminated in accordance with the terms hereof.
Re: Letter Agreement - Option to Joint Venture – Suyckutambo Silver ProjectRoyalty Agreement • June 1st, 2007 • De Beira Goldfields Inc. • Metal mining • Ontario
For good and valuable consideration, the receipt and sufficiency of which is acknowledged by each of the Parties, the Parties covenant and agree as follows:
Royalty AgreementRoyalty Agreement • December 14th, 2007 • Syntax-Brillian Corp • Radio & tv broadcasting & communications equipment • Hong Kong
This Agreement (the “Agreement”), entered into this 27th day of November, 2007, by and between SOUTH CHINA HOUSE OF TECHNOLOGY CONSULTANTS LTD., (“SCHOT”) a company duly established and existing pursuant to the laws of Hong Kong with its registered office at Unit 1303-04, Block B Sea View Estate, 2-8 Watson Road. North Point, Hong Kong; OLEVIA (FAR EAST) LIMITED (“Olevia Far East”) a company duly established and existing pursuant to the laws of Hong Kong with its registered office at Room 1801, Wing On Central Building, 26 Des Voeux Road Central, Central, Hong Kong and SYNTAX-BRILLIAN CORPORATION (“Syntax-Brillian”) a company duly established and existing pursuant to the laws of Delaware with its register office at 1600 Desert Drive, Tempe, Arizona 85281, collectively referred to as the “Parties”.
ROYALTY AGREEMENT Between Computershare Trust Company of Canada As Trustee of the PARAMOUNT ENERGY TRUST and Paramount Energy Operating Corp. As Trustee of the PARAMOUNT OPERATING TRUST Effective as of July 1, 2002Royalty Agreement • January 30th, 2003 • Paramount Energy Trust • Crude petroleum & natural gas • Alberta
EXHIBIT-E ROYALTY AGREEMENTRoyalty Agreement • February 23rd, 2011 • Solar Energy Initiatives, Inc. • Semiconductors & related devices
Solar Park Initiatives, Inc. hereby agrees to compensate Solar Energy Initiatives, Inc. an amount equal to 10% of Adjusted Gross Profit (Adjusted Gross Profit to include, but not limited to, costs of School Teachers, Commissions for Selling Class-time, Depreciation and Course Materials) derived from the operation of education programs to the Seller for a period of 3 years, ending as of February 14, 2014. Said Royalty Fee will be calculated quarterly beginning with the 3 month period ending May 30, 2011 and continuing for each subsequent three month period of time. Said Royalty Fee is payable ten (10) business days after the end of each quarter. This royalty fee is associated with the Rights of Use for licensing and non-compete as follows:
ROYALTY AGREEMENTRoyalty Agreement • March 18th, 2022 • Sharps Technology Inc. • Surgical & medical instruments & apparatus • New York
This royalty agreement is made on July 12-, 2017, effective as of July 12, 2017 (the “Effective Date”), by and between Alan Blackman, currently residing at (hereinafter referred to as “Blackman”), and Barry Berler, (hereinafter referred to as “Berler”).
ROYALTY AGREEMENTRoyalty Agreement • December 29th, 2014 • Flex Pharma, Inc. • Pharmaceutical preparations • Massachusetts
THIS ROYALTY AGREEMENT (the “Agreement”) is entered into as of March 20, 2014 (the “Effective Date”), by and between FLEX PHARMA, INC., a Delaware corporation, having offices at Prudential Tower, 800 Boylston Street, c/o Longwood Fund, Boston, MA 02199 (the “Company”), Bruce Bean, an individual with an address of 20 Locke Road, Waban, MA 02468 (“Bean”), Donald MacKinnon, an individual with an address of 305 East 85th St. Apt 17A, New York, NY 10028 (“D. MacKinnon”), Roderick MacKinnon, an individual with an address of 504 East 63rd Street, Apt 33M, New York, NY 10065 (“R. MacKinnon,” and together with Bean and D. MacKinnon, the “Scientific Founders”) and Christoph Westphal, an individual with an address of 17 Hawes Street, Brookline, MA 02446 (“Westphal,” and together with the Scientific Founders, the “Founders”). Each of Company, Bean, D. MacKinnon, R. MacKinnon and Westphal may be referred to in this Agreement as a “Party” and collectively as the “Parties.”
ROYALTY AGREEMENT (Apache County Land & Ranch)Royalty Agreement • May 2nd, 2014 • Prospect Global Resources Inc. • General bldg contractors - residential bldgs • Arizona
THIS ROYALTY AGREEMENT (“Royalty Agreement”), dated as of April 29, 2014, is made by and between Apache County Land & Ranch, LLC, a Nevada limited liability company (the “Company”), and The Karlsson Group, Inc., an Arizona corporation, (“Karlsson”) (sometimes referred to collectively, as the “Parties,” and individually, as a “Party”) with reference to the following facts and intentions:
NPR ROYALTY AGREEMENTRoyalty Agreement • July 9th, 2008 • BE Resources Inc. • Colorado
THIS AGREEMENT WITNESSES THAT, in consideration of the premises and the respective covenants and agreements hereinafter set forth in this agreement and other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged), the parties do covenant and agree with one another as follows:
ROYALTY AGREEMENTRoyalty Agreement • October 17th, 2023 • Impact Biomedical Inc. • Pharmaceutical preparations • Delaware
THIS ROYALTY AGREEMENT (the “Agreement”), made and entered into as of August 15, 2018 (the “Execution Date”), is by and between Global BioLife Inc., a Nevada corporation (“GBLI”) whose address is 4800 Montgomery Lane, Ste 210, Bethesda, MD, 20814 and Chemia Corporation, a Missouri corporation (“CHEMIA”) whose address is 11558 Rock Island Ct, Maryland Heights, MO 63043.
ContractRoyalty Agreement • December 21st, 2007 • Sunovia Energy Technologies Inc • Metal mining • Florida
ROYALTY AGREEMENT This agreement is made and entered into by and between Sparx Inc., a corporation organized and existing under the laws of the State of Florida and have an address at 1358 Fruitville Road, Suite 209, Sarasota FL 34236 ("SPARX") and Sologic, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal place of business at 1358 Fruitville Road, Suite 209, Sarasota, FL 34236 ("SOLOGIC").
AMENDED AND RESTATED ROYALTY AGREEMENTRoyalty Agreement • October 11th, 2006 • Integrated Security Systems Inc • Communications equipment, nec • Texas
This Amended and Restated Royalty Agreement (“Agreement”) is made as of October 6, 2006, by and among Integrated Security Systems, Inc., a Delaware corporation (“ISSI”), B&B ARMR Corporation, a Delaware corporation and wholly owned subsidiary of ISSI (“B&B”), Intelli-Site, Inc., a Texas corporation and wholly owned subsidiary of ISSI (“Intelli-Site”), DoorTek Corporation, a Texas corporation and wholly owned subsidiary of ISSI (“DoorTek” and, together with ISSI, B&B and Intelli-Site, the “ISSI Entities”), Renaissance Capital Growth & Income Fund III, Inc., a Texas corporation (“Renn III”), US Special Opportunities Trust PLC, a public limited company registered in England and Wales (formerly known as BFS US Special Opportunities Trust PLC (“BFS”)), Renaissance US Growth Investment Trust PLC (“RUSGIT” and, together with Renn III and BFS, collectively, the “Renaissance Funds”), and Renn Capital Group, Inc. (the “Agent”), solely as agent for the Renaissance Funds and not on its own behalf.
Contract number (FI No): 89427 Contract number (FI No): 89987 Serapis No: 2018-0245 European Investment Bank (the Bank) - and - Nanobiotix (the Company) Royalty Agreement Matter ref 1M0186.000509 PAARB/1864409 Hogan Lovells (Paris) LLP 17 avenue...Royalty Agreement • November 20th, 2020 • Nanobiotix S.A. • Pharmaceutical preparations
EXHIBIT 10.10 ROYALTY AGREEMENT This Royalty Agreement is made this ____ day of June, 2000 by and between BORS International, L.L.C. ("BIL"), Ennotech, Inc. ("Etech"), and EarthFirst Technologies, Inc. ("EarthFirst"). A. On June ____, 2000, Etech,...Royalty Agreement • April 16th, 2001 • Earthfirst Technologies Inc • Miscellaneous manufacturing industries
ROYALTY AGREEMENTRoyalty Agreement • November 14th, 2014 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
THIS AGREEMENT (“Agreement”) effective as of August 20, 2014, between EMISPHERE TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Delaware (“Company”) and (i) MHR Capital Partners Master Account LP, a limited partnership organized in Anguilla, British West Indies (“Master Account”), (ii) MHR Capital Partners (100) LP, a Delaware limited partnership (“Capital Partners (100)”), (iii) MHR Institutional Partners II LP, a Delaware limited partnership (“Institutional Partners II”) and (iv) MHR Institutional Partners IIA LP, a Delaware limited partnership (“Institutional Partners IIA”). Each of Master Account, Capital Partners (100), Institutional Partners II and Institutional Partners IIA shall be referred to herein as a “MHR Fund” and collectively as the “MHR Funds”.
